accSIS software

accSIS is a proprietary Clinical Trial Management System (CTMS) solution designed for optimum project oversight of every aspect of a study. Another accSIS feature acts as a central repository for important study documents (eTMF). accSIS is the shared platform for the sponsor and the study team, keeping everyone up to date on all the reports, analysis and dashboards involved. There’s also a feature allowing third party vendors to get interfaced into accSIS to create a single report for a sponsor.

accSIS interconnects study participants

accSIS – CTMS with lots of extras

accSIS, allows everybody involved in a study (sponsor, PMs of CRO, CRAs, other vendors) to share their information and document the progress of the trial. accSIS offers dashboards and standard reports. Reports can easily be adapted to the sponsor’s needs. Multiple export/import functions and interfaces enable connectivity to other software solutions of third party vendors or the sponsor. Green-light processes keep you updated on necessary actions and overall status (at sites or in different countries, for example). accSIS is much more than a CTMS solution. It also features:

  • Electronic Trial Master File (eTMF) functionality
  • Investigational Medicinal Product (IMP) management system
  • eLearning module
  • Project risk management
  • Site payment management module

accSIS – a quick snapshot of every aspect of project status

Functionalities in detail include:

  • Status of sites (contacted, interested, participating, contract executed, etc.)
  • Study team details (names, roles, contact info)
  • Status of patient recruitment overall and per site (planned, screened, baseline, etc.)
  • Patient overview
  • Regulatory status of sites and countries
  • Monitoring overview (date of visit, reports, planned visits etc.)
  • Training (GCP, SOP, project specific training) overview
  • Contact overview (contact details of all participating CRO staff)
  • FAQ compendium
  • Compendium for shared forms & docs

and much more.

© 2022 SSS International Clinical Research